Prostate Cancer Risk Assessment
Areas of Expertise
Gauging Your Prostate Health
Prostate cancer is the most common non-cutaneous malignancy in men. The prostate gland is a sexual organ, and the disease and its treatment can have a devastating impact on a man’s sexual health and overall well-being. PSA testing and prostate-cancer screening are controversial, however: The general medical community often fails to understand such intricacies and, in order to keep costs down, sometimes withholds proper screening technologies from patients.
By contrast, Obsidian believes that cost reduction should not be the primary concern when screening men for a potentially life-threatening malignancy, and we treat every client with an individualized risk assessment, not a one-size-fits-all approach. Our comprehensive technologies include Prostarix testing and advanced PSA derivatives such as PSA velocity, PSA density, percentage of free PSA and complexed-PSA testing, which can greatly improve diagnosis accuracy and guard against unnecessary prostate biopsies. Advanced testing is available for anyone concerned about the health of his prostate, and Obsidian consultants will take the time to discuss screening controversies and answer all questions you have about this delicate subject.
Should further diagnostic testing be required, we offer concierge-level prostate biopsies in order to minimize discomfort and improve the accuracy of the diagnosis. As part of our advanced genetic testing, we use one of the world’s foremost experts on prostate pathology, whose diagnostic acumen is second to none, to examine your tissue samples.
Learn about patients for whom Obsidian was the right choice.
Prostate cancer is the most common non-cutaneous malignancy in men, and Obsidian’s risk assessment is individualized and thorough to ensure proper treatment should any be needed.